For example, miR-218 attenuates the resistance of gastric cancer cells to cisplatin by targeting survivin [23], while miR-142-5p promotes cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes [24]. This evidence concerns the gene BIRC5 and ovarian carcinoma.